GetTopicDetailResponse(id=55b410661257, topicName=卡度尼利, introduction=卡度尼利, content=卡度尼利二線治療NSCLC, image=null, comments=1, allHits=1128, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=4754896, adminEncryptionId=f63e4754896, adminName=俠膽醫(yī)心, createdBy=f63e4754896, createdName=俠膽醫(yī)心, createdAvatar=, createdTime=Sun Sep 10 11:15:19 CST 2023, time=2023-09-10, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=479851, tagList=[TagDto(tagId=479851, tagName=卡度尼利)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2198418, encodeId=34a321984188f, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a> <a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫檢查點(diǎn)抑制劑#</a> <a href='/topic/show?id=55b410661257' target=_blank style='color:#2F92EE;'>#卡度尼利#</a> <a href='/topic/show?id=75b511336ef7' target=_blank style='color:#2F92EE;'>#G/GEJ腺癌#</a> <a href='/topic/show?id=b162113368e8' target=_blank style='color:#2F92EE;'>#AACR 2024#</a>, objectTitle=總生存率高達(dá)57.3%！北腫季加孚：雙抗治胃癌，可帶來18個月生存獲益 | AACR 2024, objectType=article, longId=820293, objectId=04a982029347, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/close-up-of-doctors-with-clipboard-at-hospital-PXE5DKE.jpg, objectUrl=/article/show_article.do?id=04a982029347, replyNumber=0, likeNumber=179, createdTime=2024-04-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=04a982029347, moduleTitle=總生存率高達(dá)57.3%！北腫季加孚：雙抗治胃癌，可帶來18個月生存獲益 | AACR 2024, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=04a982029347)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174944, encodeId=bbaf21e494490, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化療#</a> <a href='/topic/show?id=826a10860295' target=_blank style='color:#2F92EE;'>#晚期食管鱗狀細(xì)胞癌#</a> <a href='/topic/show?id=55b410661257' target=_blank style='color:#2F92EE;'>#卡度尼利#</a>, objectTitle=陳小兵教授：免疫雙抗卡度尼利聯(lián)合化療一線治療晚期食管鱗狀細(xì)胞癌（ESCC）的研究解讀, objectType=article, longId=804858, objectId=804880485849, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=804880485849, replyNumber=0, likeNumber=165, createdTime=2023-12-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=804880485849, moduleTitle=陳小兵教授：免疫雙抗卡度尼利聯(lián)合化療一線治療晚期食管鱗狀細(xì)胞癌（ESCC）的研究解讀, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=804880485849)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2156979, encodeId=1f8621569e9b5, content=<a href='/topic/show?id=55b410661257' target=_blank style='color:#2F92EE;'>#卡度尼利#</a>二線治療<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a>, objectTitle=Lung Cancer：雙免疫新藥卡度尼利二線治療NSCLC的臨床試驗(yàn)失敗（AK104-202研究）, objectType=article, longId=790963, objectId=7f86e9096395, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230910/1694307022900_4754896.png, objectUrl=/article/show_article.do?id=7f86e9096395, replyNumber=0, likeNumber=153, createdTime=2023-09-10, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7f86e9096395, moduleTitle=Lung Cancer：雙免疫新藥卡度尼利二線治療NSCLC的臨床試驗(yàn)失?。ˋK104-202研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f86e9096395)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
俠膽醫(yī)心
2023-09-10發(fā)表于上海
